PURPOSEWeight gain is a known adverse event (AE) of alectinib. This study evaluates the progression of actual weight gain over time and explores its association with baseline characteristics.METHODSA pooled analysis of individual patient data from four …
PURPOSERemote symptom monitoring of patients with cancer has previously shown potential for improving clinical outcomes. This study aimed to evaluate the effects of remote symptom…
Click on the article title to read more.
Nature Metabolism – Sellers, van Beek and colleagues show that intermittent cold exposure for 10 days, which induced 1 h of shivering per day, improves glucose homeostasis,…
Access Google Forms with a personal Google account or Google Workspace account (for business use).
As reported in The New England Journal of Medicine by Andre et al, interim analysis of the phase III CheckMate 8HW trial has shown that…
The Reagan-Udall Foundation for the FDA is an independent 501(c)(3) not-for-profit organization created by Congress for the purpose of advancing regulatory science – science that…
FDA does not issue approval announcements for every approval or drug label update that occurs in oncology and hematology.
This model-based study using population-level cancer mortality data evaluates the association of prevention, screening, and treatment interventions with cumulative number of cancer deaths averted from…
The prevalence of prostate cancer reaches between 30% and 50% in autopsy studies among men who died from other causes.1 With this large occult disease…
